You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Inhaled corticosteroid (ICS)

Showing 1 - 25 of 3,716
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Vivatmo proTM EU-study: FeNO Monitoring in Asthmatic Patients

Active, not recruiting
  • Asthma
  • FeNO measurement
  • Kralupy Nad Vltavou, Czechia
  • +4 more
Sep 21, 2022

South Korea Using Medical Records to Look at Different

Completed
Has Results
  • Pulmonary Disease, Chronic Obstructive
  • Long-acting Muscarinic Antagonists (LAMA)
  • Inhaled corticosteroid (ICS)/Long-acting Beta Agonists (LABA)
  • Seoul, Korea, Republic of
    Konkuk University Medical Center
Feb 8, 2022

Asthma, Asthma in Children Trial in United States (Vivatmo pro FeNO Test)

Completed
Has Results
  • Asthma
  • Asthma in Children
  • Vivatmo pro FeNO Test
  • Birmingham, Alabama
  • +5 more
May 11, 2022

COPD Trial in Dundee, Kirkcaldy (ICS withdrawal protocol, Standard care)

Suspended
  • Chronic Obstructive Pulmonary Disease
  • ICS withdrawal protocol
  • Standard care
  • Dundee, Perthshire, United Kingdom
  • +1 more
Jan 20, 2022

Asthma Trial in Worldwide (Rilzabrutinib, )

Recruiting
  • Asthma
  • Berazategui, Buenos Aires, Argentina
  • +24 more
Dec 29, 2022

Exacerbation Risk in Asthma

Completed
  • Asthma
  • White Plains, New York
    eMax Health
Aug 12, 2022

COPD Trial in Chongqing (Glucocorticoids, Antibiotics, Inhaled corticosteroid (ICS))

Completed
  • Chronic Obstructive Pulmonary Disease
  • Chongqing, Chongqing, China
    Daping Hospital
Oct 22, 2020

Asthma Trial in Evanston (Electronic Medication Monitors on ICS and SABA - Active Mode, Electronic Medication Monitors on ICS

Completed
  • Asthma
  • Electronic Medication Monitors on ICS and SABA - Active Mode
  • +7 more
  • Evanston, Illinois
    NorthShore University HealthSystem
Apr 2, 2020

COPD Trial in Miami (Bevespi, Bretzri)

Recruiting
  • Chronic Obstructive Pulmonary Disease
  • Miami, Florida
    University of Miami
Jan 23, 2023

Tiotropium + Olodaterol Versus Inhaled Corticosteroids +

Active, not recruiting
  • Pulmonary Disease, Chronic Obstructive
  • Tiotropium (Tio)
  • +4 more
  • Taipei, China
    National Tawain University Hospital
Jan 9, 2023

Using Specific Tests in Preschool Wheeze to Help us Determine

Active, not recruiting
  • Wheezing
  • Blood eosinophil count
  • +2 more
  • Oxford, United Kingdom
    John Radcliffe Hospital
Oct 10, 2022

Cough Trial in Guangzhou (Beclometasone Dipropionate and Formoterol Inhalation Aerosol, Placebo)

Not yet recruiting
  • Cough
  • Beclometasone Dipropionate and Formoterol Inhalation Aerosol
  • Placebo
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Guangzhou Medical University
Jun 2, 2023

Asthma Trial in Spain (To compare in both treatment arms the percentage of patients controlled at week 52.)

Recruiting
  • Asthma
  • To compare in both treatment arms the percentage of patients controlled at week 52.
  • Inca, Baleares, Spain
  • +16 more
Jun 16, 2023

Asthma, Nonadherence, Medication Trial in Saint Louis (Adherence to symptom driven budesonide/formoterol as compared to

Recruiting
  • Asthma
  • Nonadherence, Medication
  • Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABA
  • Saint Louis, Missouri
    Washington University in St. Louis School of Medicine
Jan 8, 2023

Asthma Trial in United States (RPT193, Placebo)

Recruiting
  • Asthma
  • San Jose, California
  • +5 more
Jul 12, 2023

Asthma Trial (Comparator: mometasone, Comparator: montelukast, Comparator: (unspecified))

Completed
Has Results
  • Asthma
  • Comparator: mometasone
  • +2 more
  • (no location specified)
Feb 7, 2022

Puerto Rican Children With Asthma

Completed
  • Asthma in Children
  • Inhaled corticosteroid (mometasone)
  • Pittsburgh, Pennsylvania
  • +1 more
Jul 6, 2022

Uncontrolled Asthma Trial (Experimental: CHF6001 3200 µg, Placebo Comparator: CHF6001 Placebo)

Not yet recruiting
  • Uncontrolled Asthma
  • Experimental: CHF6001 3200 μg
  • Placebo Comparator: CHF6001 Placebo
  • (no location specified)
Sep 7, 2023

Tiotropium and Olodaterol in Comparison to LABA/ICS

Completed
Has Results
  • COPD
  • Watertown, Massachusetts
    HealthCore, Inc.
Nov 12, 2021

Omalizumab on Corticosteroid Use, Emergency Room Visits and

Withdrawn
  • Asthma
    • (no location specified)
    Nov 23, 2021

    Status Asthmaticus Trial in Nashville (Montelukast Oral Granules, Albuterol, Corticosteroid)

    Not yet recruiting
    • Status Asthmaticus
    • Montelukast Oral Granules
    • +2 more
    • Nashville, Tennessee
      Monroe Carell Jr. Children's Hospital at Vanderbilt
    Apr 5, 2023

    Copd Trial in Assiut (SABA SAMA ICS Vs LABA LAMA ICs)

    Not yet recruiting
    • Copd
    • SABA SAMA ICS Vs LABA LAMA ICs
    • Assiut, Egypt
      Nermen Mohammed Abuelkassem
    Feb 28, 2023

    Asthma Trial (montelukast, Theophylline)

    Completed
    • Asthma
    • (no location specified)
    Feb 7, 2022

    Asthma Trial in Copenhagen NV (High Intensity Interval Training)

    Completed
    • Asthma
    • High Intensity Interval Training
    • Copenhagen NV, Denmark
      Respiratory Research Unit, Birpebjerg Hospital
    Mar 11, 2021

    Tiotropium Plus Olodaterol vs Inhaled Corticosteroids Regimens

    Withdrawn
    • Pulmonary Disease, Chronic Obstructive
    • (no location specified)
    Nov 3, 2021